 The technology is based on a technique known as ` neuromodulation ' in which electricity from a chip stimulates the nervous system to restore sight .
The revolutionary system is being commercialised by French company Pixium Vision , with clinical trials scheduled for 2016 .
The company claims it has been able to restore the sight of rats to a 20/120 .